Friday, August 28, 2026 See who Washington just made rich Go Pro · $40/mo →
Money Racket
Who Cashes In When Washington Moves
ENERGYBLM Launches 30-Year Permit for Trans-Alaska Pipeline OperationstodayDEFENSERocket Lab Wins $266M Space Force Missile Defense Contract—Suborbital Launch Niche Gets Federal Validation4 weeks agoMARKETSFTC Blocks Henkel's $725M Liquid Nails Bid—Antitrust WinstodayDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Cloud Incumbents Face Pressure, Oracle Locks in Defense Revenue4 weeks agoHEALTHCARE & FDAFDA Approves First RAS Inhibitor for Pancreatic CanceryesterdayCRYPTOSEC Settles Coinbase FOIA Suit Over Missing Gensler Texts—Crypto Compliance Pressure Eases, Coinbase Stock Gains Clarity4 weeks agoDEFENSEBoeing Lands $131B F-15 Contract—Fighter Jet DominanceyesterdayHEALTHCARE & FDACMS Stars Redo Lifts Medicare Advantage Insurers—Rating System Overhaul Favors UnitedHealth, Humana, Anthem4 weeks agoHEALTHCARE & FDACostco Enters Medicare Advantage—Retail Disruption LoomsyesterdayDEFENSEPentagon Awards Largest F-35 Spare Parts Contract—Lockheed Locks in Sustainment Revenue4 weeks agoTRADE & TARIFFSTrump's 50% Canada Tariffs Take Effect—Retailers BraceyesterdayDEFENSEHouse Passes $1.15T Defense Bill—Lockheed, Raytheon, General Dynamics Lock in Revenue4 weeks agoTRADE & TARIFFSU.S. Rolls Out Iran Sanctions—Oil Prices SlipyesterdayMARKETSSEC Explores 23-Hour Stock Trading—Market Makers and Tech Platforms Get New Revenue4 weeks agoHEALTHCARE & FDAAbbott's Dual Glucose-Ketone Monitor Wins FDA Nod2 days agoENERGYPHMSA Updates Pipeline Safety Standards—Compliance Costs Hit Operators, Benefit Inspectors4 weeks agoHEALTHCARE & FDARegeneron's Gene Therapy Wins First GSD Type Ia Approval2 days agoSEARCH DEMANDCasgevy List Price: $2.2 Million4 weeks agoDEFENSEStryker Lands $100M Defense Contract—Combat Vehicle Boost2 days agoSEARCH DEMANDData Center Power Exchange4 weeks agoTRADE & TARIFFSWalmart Deploys $2.9B Tariff Refund Into Price Cuts2 days agoTRADE & TARIFFSAmazon Gets $600M Tariff Refund—Retailers Lift Guidance on Windfall4 weeks agoTRADE & TARIFFSTrump Lifts Ground Beef Tariffs—Ranchers Face Price Pressure2 days agoTECHCommerce Awards $874M in Semiconductor R&D LOIs—Chip Makers Get Federal Backing4 weeks agoWHITE HOUSETrump Kills Affirmative Action Rules—Contractors Face Compliance Shift3 days agoHEALTHCARE & FDAFDA Revokes Petroleum-Based Food Dyes—Natural Color Makers Win4 weeks agoHEALTHCARE & FDAFDA Clears Robotic Blood Draw—Phlebotomy Shortage Eases3 days agoDEFENSEHouse Passes $95B Iran War Package—Defense Contractors Lock in Revenue4 weeks agoWHITE HOUSELabor Dept Eases Disability Hiring Rules—Contractors Save Compliance Costs3 days agoWHITE HOUSETrump Blocks Critical Minerals Exports—U.S. Miners Get Protected Market4 weeks agoWHITE HOUSELabor Dept Eases Veteran Hiring Rules—Contractors Cut Compliance3 days agoHEALTHCARE & FDAHumana Exits MA Markets—600K Members Face Plan Disruption4 weeks agoTECHCHIPS Act Transforms Binghamton Into Semiconductor Hub4 days agoENERGYMichigan Court Vacates Line 5 Permit—Enbridge Faces Shutdown Risk3 weeks agoTRADE & TARIFFSTrump Administration Targets Iran's Banking System With New Sanctions4 days agoTRADE & TARIFFSAmazon Pockets $600M Tariff Refund—Retail Rivals Face Margin Squeeze3 weeks agoTECHUtah Governor Signs Quantum Computing Initiative Order4 days agoHEALTHCARE & FDAHHS Boosts Hospital Payments by $2 Billion—Acute Care Operators Win3 weeks agoDEFENSEFAA Engine Inspection Order Lifts MRO Stocks5 days agoHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Drug Plan Insurers Face Margin Pressure3 weeks agoTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earnings5 days agoHEALTHCARE & FDACMS Raises IRF Payments for 2027—Rehab Hospitals Get Relief3 weeks agoHEALTHCARE & FDATrump Vaccine Spacing Order Reshapes Pharma Demand5 days agoTRADE & TARIFFSTrump Administration Hits $100B Tariff Refund Milestone3 weeks agoTECHD-Wave Wins Canadian Quantum Funding for Annealing5 days agoDEFENSERising Defense Spending Lifts Northrop Grumman Outlook3 weeks agoENERGYEnbridge Wins Federal Permit for Line 5 Tunnel6 days agoMARKETSFTC Threatens Booking Holdings Over Priceline Practices3 weeks agoENERGYFederal Court Orders Enbridge Line 5 Removal6 days agoHEALTHCARE & FDAFTC Sues Hims & Hers Over Privacy and Billing Practices3 weeks agoWHITE HOUSEFinCEN Finalizes BOI Exemption for U.S. Persons6 days agoHEALTHCARE & FDAFDA Approves Tudriqev for Advanced Melanoma3 weeks agoHEALTHCARE & FDAGAO Finds $7.6B Medicare Hospice Overpaymentlast weekTRADE & TARIFFSRetailers Sell Off Tariff Refund Rights for Cash—Windfall Monetized Before Payout3 weeks agoENERGYNewsom Passes Diablo Canyon Decision to Successorlast weekTECHU.S. Signs $874M Semiconductor Research LOIs—Chip Makers Get Federal Backing3 weeks agoDEFENSERTX Lands Fresh Missile Defense Contract—Stock Undervaluedlast weekWHITE HOUSEDHS Tightens H-1B/L-1 Visa Fees—Tech Hiring Costs Rise for Employers3 weeks agoTECHCommerce Eases Drone Export Rules—U.S. Makers Winlast weekENERGYMichigan Court Rejects Enbridge Line 5 Permit Under Great Lakes3 weeks agoHEALTHCARE & FDAFDA Reclassifies Cancer Tests—Easier Path for Diagnosticslast weekDEFENSEPentagon Awards Space-Based Target Tracking Contracts3 weeks agoHEALTHCARE & FDAFTC Probes Epic Systems Over Health Records Monopolylast weekTECHTrump Administration Adds 6 Chipmakers to U.S. Portfolio3 weeks agoDEFENSETrump's $1.5T Defense Push Fuels Colorado Contractor Windfalllast weekWHITE HOUSEWhite House Drafts Vaccine-Autism Order—Pharma Faces Uncertainty3 weeks agoENERGYEPA Exempts Calcium Carbonate From Pesticide Tolerance—Farm Input Easeslast weekDEFENSETrump Pushes $1.5T Defense Budget—Lockheed, RTX, GD Lock in Gains3 weeks agoWHITE HOUSETrump Vaccine Spacing Order Reshapes Pharma Demandlast weekWHITE HOUSETrump Order Splits MMR Vaccine—Pharma Faces Demand Shift2 weeks agoHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Insurers Face Pressurelast weekWHITE HOUSETrump Orders Childhood Vaccine Schedule Spacing2 weeks agoTRADE & TARIFFSTariff Refunds Flow to Retailers—Earnings Boostlast weekHEALTHCARE & FDAFDA Updates Fresh-Cut Produce Safety Guidance2 weeks agoENERGYArmy Corps Permits Line 5 Tunnel—Michigan Blocks Pathlast weekENERGYNRC Approves NAC MAGNASTOR Spent Fuel Storage Cask2 weeks agoTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earningslast weekHEALTHCARE & FDAFDA Clears Screwworm Prevention Drug for U.S. Livestock2 weeks agoCRYPTOSEC Delays Crypto Rules—Uncertainty Persistslast weekDEFENSEIonQ Lands $28M U.S. Defense Quantum Contract2 weeks agoTRADE & TARIFFSKimberly-Clark Pockets $45M Tariff Refundlast weekTECHFCC Eases Broadband Label Rules—ISPs Win Flexibility2 weeks agoTRADE & TARIFFSTrump Tariffs on Drones Boost U.S. Makerslast weekDEFENSEBlackSky Lands Multi-Year Satellite Contract2 weeks agoHEALTHCARE & FDASimparica Trio Gets Screwworm EUA—Zoetis Wins2 weeks ago
1 free article left this week. A free account gets you 4 a week.Go Pro →
Energy

BLM Launches 30-Year Permit for Trans-Alaska Pipeline Operations

Regulatory green light extends energy infrastructure revenue for operators.

Image: Money Racket
By at Money Racket · Aug 28, 2026

The Bureau of Land Management initiated the regulatory process to permit another 30 years of operations for the Trans-Alaska Pipeline System (TAPS), safeguarding continued oil transport from Prudhoe Bay to Valdez. The move reflects the Trump Administration's commitment to domestic energy security and production.

30-year permit locks in decades of throughput revenue for TAPS operators.

The direct beneficiary is the TAPS operator and owner consortium, primarily ConocoPhillips (ticker COP), ExxonMobil (ticker XOM), and BP (ticker BP, though UK-listed; U.S. exposure via ADR). ConocoPhillips holds the largest stake and operates the pipeline. The 30-year permit extension removes regulatory uncertainty and locks in decades of throughput revenue from Alaskan crude production. Downstream refiners that depend on TAPS crude—particularly West Coast refiners like Tesoro (now Marathon Petroleum, ticker MPC)—benefit from assured supply. Shipping and logistics companies that handle Valdez-to-market transport also gain.

The risk is to renewable energy advocates and climate-focused investors who oppose continued fossil fuel infrastructure. However, no public company faces direct financial pressure from the permit extension; the risk is reputational and regulatory (e.g., future carbon taxes or stricter emissions rules that could affect profitability).

Watch for: Final permit issuance (expected 2026–2027), any legal challenges from environmental groups, and ConocoPhillips' guidance on Alaskan production volumes and capital allocation.

Source: original report ↗

Free alerts

Free: catalyst alerts, straight to your inbox.

Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $40/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://moneyracket.com/article/trans-alaska-pipeline-30-year-permit-process/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Money Racket Pro

    By the time it's news, the money's already moved.

    The contract award, the executive order, the tariff cut — it mints winners before the financial press connects the dots. Pro gets you there first: what happened, who cashes in, and exactly what to watch — in a two-minute read.

    Go Pro · $40/mo The policy-to-profit brief. Cancel anytime.
    The pre-market brief · Mon–Sat, 7:45am ET Go Pro · $40/mo →